Literature DB >> 17456193

High levels of low-density lipoprotein cholesterol and triglycerides and suboptimal glycemic control predict diminished ex vivo aspirin responsiveness in patients with Type 2 diabetes.

M M C Hovens, J D Snoep, Y Groeneveld, J T Tamsma, J C J Eikenboom, M V Huisman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17456193     DOI： 10.1111/j.1538-7836.2007.02596.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  5 in total

Review 1.  Antiplatelet resistance in stroke.

Authors:  Mehmet Akif Topçuoglu; Ethem Murat Arsava; Hakan Ay
Journal:  Expert Rev Neurother       Date:  2011-02       Impact factor: 4.618

2.  Younger age, higher body mass index and lower adiponectin concentration predict higher serum thromboxane B2 level in aspirin-treated patients with type 2 diabetes: an observational study.

Authors:  Agnieszka Kaplon-Cieslicka; Marek Postula; Marek Rosiak; Michal Peller; Agnieszka Kondracka; Agnieszka Serafin; Ewa Trzepla; Grzegorz Opolski; Krzysztof J Filipiak
Journal:  Cardiovasc Diabetol       Date:  2014-08-15       Impact factor: 9.951

3.  Prevalence of and risk factors for aspirin resistance in elderly patients with coronary artery disease.

Authors:  Xian-Feng Liu; Jian Cao; Li Fan; Lin Liu; Jian Li; Guo-Liang Hu; Yi-Xin Hu; Xiao-Li Li
Journal:  J Geriatr Cardiol       Date:  2013-03       Impact factor: 3.327

4.  Aspirin resistance in patients with type II diabetes mellitus.

Authors:  Eyyup Tasdemir; Tayfur Toptas; Cengiz Demir; Ramazan Esen; Murat Atmaca
Journal:  Ups J Med Sci       Date:  2013-11-18       Impact factor: 2.384

5.  Association between High On-Aspirin Platelet Reactivity and Reduced Superoxide Dismutase Activity in Patients Affected by Type 2 Diabetes Mellitus or Primary Hypercholesterolemia.

Authors:  Cristina Barale; Franco Cavalot; Chiara Frascaroli; Katia Bonomo; Alessandro Morotti; Angelo Guerrasio; Isabella Russo
Journal:  Int J Mol Sci       Date:  2020-07-15       Impact factor: 5.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.